Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.
Lau
Johnson Y N
JY
Research and Development, ICN Pharmaceuticals Inc., Costa Mesa, CA 92626, USA. jlau@icnpharm.com
Tam
Robert C
RC
Liang
T Jake
TJ
Hong
Zhi
Z
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D012254:Ribavirin / Q000494:pharmacology*
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin